✦ LIBER ✦

Identification of “drugable” molecular targets implicated in cross-presentation by dendritic cells

✍ Scribed by Charlotte Sadaka; Paul Gerink; Boris Rodenko; Huib Ovaa; Jacques Neefjes

Book ID: 113805761
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 54 KB
Volume: 51
Category: Article
ISSN: 0161-5890
DOI: 10.1016/j.molimm.2012.02.079

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of Fc-receptors in antigen cros

The role of Fc-receptors in antigen cross-presentation by human dendritic cell subsets

✍ Thijs Flinsenberg; Ewoud Compeer; Femke Amelung; Jaap Boelens; Marianne Boes 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 65 KB

[Methods in Molecular Biology™] Macropha

[Methods in Molecular Biology™] Macrophages and Dendritic Cells Volume 531 || Identification of Pathogen Receptors on Dendritic Cells to Understand their Function and to Identify New Drug Targets

✍ Reiner, Neil E. 📂 Article 📅 2009 🏛 Humana Press ⚖ 333 KB

Limited sufficiency of antigen presentat

Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity

✍ Gregory F. Wu; Kenneth S. Shindler; Eric J. Allenspach; Tom L. Stephen; Hannah L 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 617 KB

Induction of complete and molecular remi

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

✍ Van Tendeloo, V. F.; Van de Velde, A.; Van Driessche, A.; Cools, N.; Anguille, S 📂 Article 📅 2010 🏛 National Academy of Sciences 🌐 English ⚖ 350 KB

Induction of complete and molecular remi

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

✍ Van Tendeloo, V. F.; Van de Velde, A.; Van Driessche, A.; Cools, N.; Anguille, S 📂 Article 📅 2010 🏛 National Academy of Sciences 🌐 English ⚖ 350 KB

Active immunization using tumor antigen-loaded dendritic cells holds promise for the adjuvant treatment of cancer to eradicate or control residual disease, but so far, most dendritic cell trials have been performed in end-stage cancer patients with high tumor loads. Here, in a phase I/II trial, we i

Identification of Molecular Target Prote

Identification of Molecular Target Proteins in Berberine-treated Cervix Adenocarcinoma HeLa Cells by Proteomic and Bioinformatic Analyses

✍ Binan Lu; Jing Zhao; Lina Xu; Yousong Xu; Xiaona Wang; Jinyong Peng 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB